Söndag 20 April | 16:49:55 Europe / Stockholm

Prenumeration

2025-03-27 09:28:00

Redeye provides an update on Xbrane following the recent deal with Alvotech, which has materially improved the company’s financial position, prompting positive revisions to our valuation model.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/